SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 277 filers reported holding SAGE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $7,049,000 | -15.6% | 38,500 | -26.7% | 1.38% | -18.4% |
Q1 2019 | $8,350,000 | +141.1% | 52,500 | +144.2% | 1.70% | +43.1% |
Q1 2018 | $3,463,000 | +250.5% | 21,500 | +258.3% | 1.19% | +210.5% |
Q4 2017 | $988,000 | +5.7% | 6,000 | -60.0% | 0.38% | +42.0% |
Q3 2017 | $935,000 | +67.9% | 15,000 | +114.3% | 0.27% | +37.9% |
Q2 2017 | $557,000 | -12.8% | 7,000 | -22.2% | 0.20% | -37.7% |
Q1 2017 | $639,000 | +36.8% | 9,000 | +12.5% | 0.31% | +30.4% |
Q4 2015 | $467,000 | -80.6% | 8,000 | -75.8% | 0.24% | -77.9% |
Q2 2015 | $2,409,000 | – | 33,000 | – | 1.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |